Clinical Trials Search Results
Results 1-10 of 446 for your search
Show Search Criteria
Your Search Criteria
Category |
Your Selection |
|---|---|
| Keywords/Phrases: | head and neck |
Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1353 locations
Age: 18 years and over
Gender: Male or Female
Location: 1353 locations
Weight Loss Interventions in Treating Overweight and Obese Women with a Higher Risk for Breast Cancer Recurrence
Status: Active
Age: 18 years and over
Gender: Female
Location: 1272 locations
Age: 18 years and over
Gender: Female
Location: 1272 locations
Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1174 locations
Age: 18 years and over
Gender: Male or Female
Location: 1174 locations
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel with or without Carboplatin in Treating Patients with Triple-Negative Breast Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1125 locations
Age: 18 years and over
Gender: Male or Female
Location: 1125 locations
Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1300 locations
Age: 18 years and over
Gender: Male or Female
Location: 1300 locations
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 845 locations
Age: 18 years and over
Gender: Male or Female
Location: 845 locations
Nivolumab after Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 850 locations
Age: 18 years and over
Gender: Male or Female
Location: 850 locations
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients with Stage III-IV BRAFV600 Melanoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 665 locations
Age: 18 years and over
Gender: Male or Female
Location: 665 locations
Pembrolizumab in Treating Patients with Triple-Negative Breast Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 707 locations
Age: 18 years and over
Gender: Male or Female
Location: 707 locations
Standard or Comprehensive Radiation Therapy in Treating Patients with Early-Stage Breast Cancer Previously Treated with Chemotherapy and Surgery
Status: Active
Age: 18 years and over
Gender: Female
Location: 576 locations
Age: 18 years and over
Gender: Female
Location: 576 locations